口服避孕药诱导肠道微生物群的时间和细分变化
Anna Clapp Organski1, Anjali Reddivari2, Lavanya Reddivari3
1Department of Nutrition Science, Purdue University, West Lafayette, IN 47907, USA.
Nutrients
|August 28, 2025
概括
口服避孕药 (OC) 的使用会改变肠道微生物群的组成,并随着时间的推移增加结肠中的雌激素水平. 这些变化可能会增加心脏代谢风险,特别是长期使用.
科学领域:
- 微生物学
- 内分泌学
- 心血管科学
背景情况:
- 口服避孕药 (OC) 广泛用于女性避孕.
- 与内源性雌激素不同,OCs中的外源性雌激素与心脏代谢疾病风险增加有关.
- 肠道微生物群在心脏代谢疾病风险中的作用是显著的,但与OC使用有关的研究不足.
研究的目的:
- 研究OC使用对肠道微生物群组成的影响.
- 探索微生物变化,肠道雌激素,能量平衡和氧化应激之间的关联.
主要方法:
- 雌性小鼠在12周或20周内接受高脂肪饮食.
- 评估了十二指肠,肠,肠的微生物群.
- 测量了体脂肪酸和肠道雌激素水平.
主要成果:
- 在12周和20周时,OC治疗导致结肠雌激素水平升高.
- 经过20周的OC使用显著改变了肠道和结肠微生物群,增加了异黄油酸.
- 微生物与能量消耗的关联因治疗时间而异.
结论:
- 口服避孕药的使用会导致特定时间和地点的肠道微生物群和脂肪酸变化.
- 长期使用的结肠雌激素增加可能会影响肠道微生物群和健康.
- 结果表明OC诱导的肠道微生物转移有助于心脏代谢风险.
相关概念视频
Anatomy of the Intestines
73.8K
Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
73.8K
Drugs for Treatment of Constipation-Predominant IBS
326
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
326
Drugs for Treatment of Diarrhea-Predominant IBS
292
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
292
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
201
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
201
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
260
Orally administered drugs primarily enter the systemic circulation via passive diffusion through the intestinal membranes. The drug's absorption is influenced by drug stability in the gastrointestinal GI tract, membrane permeability, the surface area available for absorption, luminal drug concentration, and residence time in the lumen. Drug permeability can be enhanced by adjusting the lipophilicity, polarity, or molecular size of the drug, promoting its passive transport across intestinal...
260
Drug Absorption: Factors Affecting GI Absorption
4.7K
The process of oral drug absorption can be influenced by several factors. Weakly acidic drugs tend to be absorbed more readily from the stomach due to their nonionized state. However, absorption may be less efficient in the upper intestine, where drugs are often ionized. Interestingly, despite the stomach's apparent advantage for drug absorption, its mucous layer can hinder diffusion. Its surface area is also smaller than the intestine's, which can further slow down the absorption rate.
4.7K


